A prospective analysis of the relationship between sexual acceptability and contraceptive satisfaction over time

Kramer, Renee D.; Higgins, Jenny A.; Everett, Bethany G.; Turok, David K.; Sanders, Jessica N.

doi:10.1016/j.ajog.2021.10.008

Cited by 2 publications

(3 citation statements)

References 40 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In our analysis, we also examined method satisfaction among continuing users at 6, 24, and 36 months and found that for each contraceptive method approximately nine in 10 continuing users were satisfied. Our findings of high method satisfaction are like those of other studies with longitudinal assessments of method satisfaction (Ela et al 2022;Hubacher et al 2018;Peipert et al 2011;Kramer et al 2022;Costescu et al 2022).…”

Section: Discussionsupporting

confidence: 89%

Continuation of Reversible Contraception Following Enrollment in the Zika Contraception Access Network (Z‐CAN) in Puerto Rico, 2016–2020

Zapata,

Kortsmit,

Curtis

et al. 2024

Studies in Family Planning

View full text Add to dashboard Cite

The Zika Contraception Access Network (Z‐CAN) provided access to high‐quality client‐centered contraceptive services across Puerto Rico during the 2016–2017 Zika virus outbreak. We sent online surveys during May 2017–August 2020 to a subset of Z‐CAN patients at 6, 24, and 36 months after program enrollment (response rates: 55–60 percent). We described contraceptive method continuation, method satisfaction, and method switching, and we identified characteristics associated with discontinuation using multivariable logistic regression. Across all contraceptive methods, continuation was 82.5 percent, 64.2 percent, and 49.9 percent at 6, 24, and 36 months, respectively. Among continuing users, method satisfaction was approximately ≥90 percent. Characteristics associated with decreased likelihood of discontinuation included: using an intrauterine device or implant compared with a nonlong‐acting reversible contraceptive method (shot, pills, ring, patch, or condoms alone); wanting to prevent pregnancy at follow‐up; and receiving as their baseline method the same method primarily used before Z‐CAN. Other associated characteristics included: receiving the method they were most interested in postcounseling (6 and 24 months) and being very satisfied with Z‐CAN services at the initial visit (6 months). Among those wanting to prevent pregnancy at follow‐up, about half reported switching to another method. Ongoing access to contraceptive services is essential for promoting reproductive autonomy, including supporting patients with continued use, method switching, or discontinuation.

show abstract

Section: Discussionsupporting

confidence: 89%

Continuation of Reversible Contraception Following Enrollment in the Zika Contraception Access Network (Z‐CAN) in Puerto Rico, 2016–2020

Zapata,

Kortsmit,

Curtis

et al. 2024

Studies in Family Planning

View full text Add to dashboard Cite

show abstract

“…In addition to ease-of-use and side effects, recent data on 1879 individuals from the HER Salt Lake Contraceptive Initiative found that sexual experience is also contributing factor toward contraceptive satisfaction [227]. IUD or implant users reporting “improved their sex life a lot” have 7.7 times increased odds of greater contraceptive satisfaction at 3 months while users reporting “improved their sex life a ‘little’” had 5.88 times increased odds of greater satisfaction [227]. Users reporting no effect to their sex life had also 5.10 times increased odds of greater satisfaction [227].…”

Section: Perspectives For Future Developmentmentioning

confidence: 99%

“…IUD or implant users reporting “improved their sex life a lot” have 7.7 times increased odds of greater contraceptive satisfaction at 3 months while users reporting “improved their sex life a ‘little’” had 5.88 times increased odds of greater satisfaction [227]. Users reporting no effect to their sex life had also 5.10 times increased odds of greater satisfaction [227].…”

Section: Perspectives For Future Developmentmentioning

confidence: 99%

Reversible female contraceptives: historical, current, and future perspectives

Barton,

Erickson,

Allred

et al. 2023

Biology of Reproduction

View full text Add to dashboard Cite

Contraception is a practice with extensive and complicated social and scientific histories. From cycle tracking, to the very first prescription contraceptive pill, to now having over-the-counter contraceptives on demand, family planning is an aspect of healthcare that has undergone and will continue to undergo several transformations through time. This review provides a comprehensive overview of current reversible hormonal and non-hormonal birth control methods as well as their mechanism of action, safety, and effectiveness specifically for individuals who can become pregnant. Additionally, we discuss the latest Food and Drug Administration (FDA)-approved hormonal method containing estetrol and drospirenone that has not yet been used worldwide as well as the first FDA-approved hormonal over-the-counter progestin-only pills. We also review available data on novel hormonal delivery through microchip, microneedle, and the latest FDA-approved non-hormonal methods such as vaginal pH regulators. Finally, this review will assist in advancing female contraceptive method development by underlining constructive directions for future pursuits. Information was gathered from the NCBI and Google Scholars databases using English and included publications from 1900 to present. Search terms included contraceptive names as well as efficacy, safety, and mechanism of action. In summary, we suggest that investigators consider the side effects and acceptability together with the efficacy of contraceptive candidate towards their development.

show abstract

A prospective analysis of the relationship between sexual acceptability and contraceptive satisfaction over time

Cited by 2 publications

References 40 publications

Continuation of Reversible Contraception Following Enrollment in the Zika Contraception Access Network (Z‐CAN) in Puerto Rico, 2016–2020

Continuation of Reversible Contraception Following Enrollment in the Zika Contraception Access Network (Z‐CAN) in Puerto Rico, 2016–2020

Reversible female contraceptives: historical, current, and future perspectives

Contact Info

Product

Resources

About